RoosterBio: ShiftBio Partners with RoosterBio to Accelerate Development of a Novel Genetically Engineered Exosome, SBI-102
FREDERICK, MARYLAND, UNITED STATES, April 26, 2022 /EINPresswire.com/ -- ShiftBio, a leader in the development of innovative exosome platform technologies, announced today a strategic partnershi...
Read full article »
RoosterBio is a Maryland-based biotechnology company that develops products such as stromal cells and human exosomes for cell and gene therapy applications.
Read more